Jacob S. Aday

发表

Extended testing with the dot-probe task increases test–retest reliability and validity

Joshua M. Carlson, Jacob S. Aday, 2018, Cognitive Processing.

Changes in prefrontal cortex near infrared spectroscopy activity as a function of difficulty in a visual P300 paradigm

Joshua M. Carlson, Jacob S. Aday, W. Rizer, 2018, Journal of Near Infrared Spectroscopy.

Structural MRI-based measures of neuroplasticity in an extended amygdala network as a target for attention bias modification treatment outcome.

Joshua M. Carlson, Jacob S. Aday, 2017, Medical hypotheses.

EVALUATING THE USE OF SELF-RELEVANT STIMULI IN ATTENTION BIAS MODIFICATION TRAINING AS A TREATMENT FOR ANXIETY: A NEAR-INFRARED SPECTROSCOPY STUDY

Jacob S. Aday, 2017 .

Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2019, Journal of psychoactive drugs.

Psychedelics and virtual reality: parallels and applications

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2020, Therapeutic advances in psychopharmacology.

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.

Jacob S. Aday, Alan K. Davis, Christopher Davoli, 2021, ACS pharmacology & translational science.

2019: A year of expansion in psychedelic research, industry, and deregulation

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2020 .

Long-term effects of psychedelic drugs: A systematic review

Jacob S. Aday, Alan K. Davis, Christopher Davoli, 2020, Neuroscience & Biobehavioral Reviews.

In the presence of conflicting gaze cues, fearful expression and eye-size guide attention

Joshua M. Carlson, Jacob S. Aday, 2018, Cognition & emotion.

Meditation alters representations of peripersonal space: Evidence from auditory evoked potentials

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2020, Consciousness and Cognition.

Neural Mechanisms of Emotions and Affect

Joshua M. Carlson, Jacob S. Aday, W. Rizer, 2017 .

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

Jacob S. Aday, D. Nutt, A. Schlag, 2022, Journal of psychopharmacology.

Neurotensin NTS1 and NTS2 receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in rats

Jacob S. Aday, A. Prus, Floyd F. Steele, 2017, Brain Research.

Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

Jacob S. Aday, B. Heifets, J. Woolley, 2021, Psychopharmacology.

Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2020, Journal of Cognitive Enhancement.

Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2019, Journal of Cognitive Enhancement.

Psychedelic drugs and perception: a narrative review of the first era of research

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2021, Reviews in the neurosciences.

2018: A watershed year for psychedelic science

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2019, Drug Science, Policy and Law.

Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice

Jacob S. Aday, M. Pleet, Ellen R. Bradley, 2023, Psychedelic Medicine.

Eye-size effects in the dot-probe task: Greater sclera exposure predicts delayed disengagement from fearful faces

Joshua M. Carlson, Jacob S. Aday, L. Fang, 2023, PloS one.

Extended testing with the dot-probe task increases test–retest reliability and validity

Joshua M. Carlson, Jacob S. Aday, 2018, Cognitive Processing.

Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA

Jacob S. Aday, D. Nutt, H. Curran, 2021, Journal of psychopharmacology.

Temporal dynamics in attention bias: effects of sex differences, task timing parameters, and stimulus valence

Joshua M. Carlson, Jacob S. Aday, D. Rubin, 2018, Cognition & emotion.

Emerging Challenges for Psychedelic Therapy.

Jacob S. Aday, R. Carhart-Harris, J. Woolley, 2023, JAMA psychiatry.

Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry

Jacob S. Aday, P. Hendricks, K. Murnane, 2023, Psychedelic Medicine.

Slowhand: Does time perception change in peri-hand space?

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2019, Psychonomic Bulletin & Review.

Neurotensin NTS1 and NTS2 receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in rats

Jacob S. Aday, A. Prus, Floyd F. Steele, 2017, Brain Research.

Psychedelic-assisted psychotherapy: where is the psychotherapy research?

Jacob S. Aday, Gisele Fernandes-Osterhold, David Horton, 2024, Psychopharmacology.

Neuroscience and Biobehavioral Reviews

Jacob S. Aday, Christopher Davoli, Emily K Bloesch, 2022 .